Legal Representation
Attorney
Salvatore J. Abbruzzese
USPTO Deadlines
Next Deadline
250 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-03-17)
Due Date
March 17, 2026
Grace Period Ends
September 17, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
24 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 17, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Mar 17, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Feb 14, 2020 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Feb 13, 2020 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Feb 5, 2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Feb 5, 2020 | DPCC | D | DIVISIONAL PROCESSING COMPLETE |
| Feb 5, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jan 7, 2020 | IUAF | S | USE AMENDMENT FILED |
| Jan 7, 2020 | DRRR | I | DIVISIONAL REQUEST RECEIVED |
| Jan 7, 2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Jan 7, 2020 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED |
| Dec 10, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Oct 15, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Oct 15, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Sep 25, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sep 5, 2019 | ALIE | A | ASSIGNED TO LIE |
| Sep 4, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 4, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Sep 4, 2019 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Sep 4, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Sep 4, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Sep 3, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
| Jun 24, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jun 14, 2019 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Biological bone tissue, namely, allogenic tissue intended for subsequent implantation in medical and surgical procedures, namely, bone matrix, viable cell, amniotic membrane and structural allografts; human allograft tissue, namely, allogenic tissue intended for subsequent implantation in medical and surgical procedures, namely, bone matrix, viable cell, amniotic membrane and structural allografts
First Use Anywhere:
Nov 4, 2019
First Use in Commerce:
Nov 4, 2019
Classification
International Classes
005